Temple University, Office of Physician & Faculty Recruitment

Fels Cancer Institute for Personalized Medicine- Tenure Track Faculty

Job Locations US-PA-Philadelphia
Posted Date 2 months ago(1/27/2023 4:07 PM)
Specialty Area
Fels Institute-Basic Science

Summary of Position

The Fels Cancer Institute for Personalized Medicine and The Lewis Katz School of Medicine at Temple University invite applications for tenure track position at the Assistant, Associate or Full Professor rank.


We seek investigators interested in establishing and maintaining a vigorous, extramurally funded cancer research program in the areas of cancer genomics, epigenomics and metabolomics, basic cancer biology or experimental therapeutics, with special emphasis on personalized medicine.


The existing research programs in the Fels Institute are diverse and include programs in genetics and epigenetics of cancer, cancer biology, signal transduction, cell growth control, single cell “omics”, synthetic lethality, and developmental biology. To learn more about the Institute click here.


In addition to a competitive salary, start-up funds, newly renovated laboratory space and comprehensive suite of benefits – including a generous 403b retirement match, health, dental, vision, life, tuition remission, paid vacation and more – the position offers:
• a uniquely supportive academic environment strengthened by Temple’s mission-driven culture to provide and promote world class research;
• individual career development, and collegiality among faculty members.


Job Qualifications: PhD, M.D., or equivalent degree in a biological discipline and demonstrated potential for excellence in research.


Temple Health is one of Philadelphia's leading academic medical centers, with 20 clinical departments; 8 Basic Science Departments; 13 Research Centers (all of which are engaged in research, education, and patient care) and more than 1,000 scientists and physicians sharing the mission of performing world-class research and translating the innovative discoveries to the bedside.


Procedure for Candidacy
In order to be considered for this position, you must complete an online application. Your application will not be considered complete until you have submitted all of the required documents and information. All documents must be in PDF format.


Application materials should include: a cover letter stating area of expertise and qualifications; a current curriculum vitae; synopses of research and teaching interests, accomplishments, and professional goals; and three letter of reference or contact information for 3 professional references (name, title, email address and phone number for each). A statement describing participation in activities that promote diversity and inclusion and/or plans to make future contributions is strongly encouraged.


Please address your application to: Tomasz Skorski, Director of the Fels Cancer Institute for Personalized Medicine; C/O Jessica Vega, Sr. Physician/Faculty Recruiter, Lewis Katz School of Medicine at Temple University.


For confidential inquires and or questions about the opportunity please contact Jessica N. Vega, Senior Physician/Faculty Recruiter, at jessica.vega@tuhs.temple.edu


We are especially interested in qualified candidates from diverse backgrounds and under-represented groups. For more information about diversity at the Lewis Katz School of Medicine, please visit the Office of Health Equity, Diversity and Inclusion.


COVID-19 vaccinations are required for employment at Temple University, unless granted a religious or medical exemption (see www.temple.edu/coronavirus)


The University is especially interested in qualified candidates who can contribute through their research, teaching, and/or service to the diversity and excellence of the academic community. Lewis Katz School of Medicine at Temple University is an Affirmative Action/Equal Opportunity Employer and strongly encourages applications from women, minorities, veterans, and persons with disabilities.


Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed